Earnings Call Summary | DocGo(DCGO.US) Q1 2024 Earnings Conference
Earnings Call Summary | DocGo(DCGO.US) Q1 2024 Earnings Conference
The following is a summary of the DocGo Inc. (DCGO) Q1 2024 Earnings Call Transcript:
以下是DocGo Inc.（DCGO）2024年第一季度業績電話會議記錄的摘要：
Financial Performance:
財務業績：
DocGo's Q1 2024 revenue reached $192.1 million and recorded an adjusted EBITDA of $24.1 million.
Due to termination of migrant-related projects more rapidly than expected, the company has revised its financial forecast. It now anticipates full-year 2024 revenues between $600 million and $650 million, and an adjusted EBITDA ranging from $65 million to $75 million.
A forecasted decrease in annual revenue by roughly $100 million is predicted due to a dip in migrant-related projects.
Q1 saw high revenues but these are anticipated to decline in Q2, Q3, and further into Q4 due to a significant drop in HPD revenue.
DocGo的2024年第一季度收入達到1.921億美元，調整後的息稅折舊攤銷前利潤爲2410萬美元。
由於移民相關項目的終止速度快於預期，該公司修改了財務預測。該公司現在預計2024年全年收入在6億美元至6.5億美元之間，調整後的息稅折舊攤銷前利潤在6500萬美元至7500萬美元之間。
由於移民相關項目的減少，預計年收入將減少約1億美元。
第一季度收入很高，但由於HPD收入大幅下降，預計第二季度、第三季度收入將下降，並進一步下降到第四季度。
Business Progress:
業務進展：
DocGo is broadening its care gap closure programs with key insurance companies and continues to make meaningful progress in offering health services to underserved communities.
Two new initiatives include a primary care offering and a mobile X-ray program.
Revenue generated from various segments in 2024: non-migrant mobile health revenues are predicted at approximately $105 million, with transportation revenues expected to hit $195 million.
Aiming for growth into 2025, the company is targeting $400 million in revenue from their base business, an increase of over 30% from 2024.
They also foresee growth of around 15% in the medical transportation business into 2023 to 2025. The monitoring business, though small, is the fastest growing, with growth expected from expanding existing payer associations and fostering new ones.
Expansion of healthcare offerings will also come from introducing more mobile health programs with health system partners.
Upcoming municipal business expansion will focus on core medical services such as vaccination deployment and behavioral health care services.
High growth rates are expected in the virtual primary care business, aiming to serve patients who lack access to persistent healthcare.
A $70 million to $80 million cash flow from operations is expected for 2024, slightly higher than the projected EBITDA.
DocGo正在擴大與主要保險公司的醫療差距縮小計劃，並在向服務不足的社區提供醫療服務方面繼續取得有意義的進展。
兩項新舉措包括初級保健服務和移動X射線計劃。
2024年各細分市場產生的收入：非移民移動醫療收入預計約爲1.05億美元，交通收入預計將達到1.95億美元。
該公司的目標是到2025年實現增長，目標是從其基礎業務中獲得4億美元的收入，比2024年增長30％以上。
他們還預計，到2023年至2025年，醫療運輸業務將增長約15％。監控業務雖然規模不大，但增長最快，預計增長將來自擴大現有付款人協會和培育新的付款人協會。
擴大醫療保健服務還將來自於與衛生系統合作夥伴一起推出更多的移動醫療計劃。
即將到來的市政業務擴張將側重於核心醫療服務，例如疫苗接種部署和行爲醫療保健服務。
虛擬初級保健業務預計將實現高增長率，旨在爲無法獲得持續醫療保健的患者提供服務。
預計2024年的運營現金流爲7,000萬至8000萬美元，略高於預計的息稅折舊攤銷前利潤。
More details: DocGo IR
更多詳情： DocGo IR
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。